Picture of Invivyd logo

IVVD — Invivyd News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Invivyd Inc reports results for the quarter ended in June - Earnings Summary

* Invivyd Inc  IVVD.OQ  reported a quarterly adjusted loss
of 40
cents​​ per share for the quarter ended in June, higher than the
same quarter last year, when the company reported EPS of -46
cents.  The mean expectation of three analysts for the quarter
was for a loss of 37 cents per share. Wall Street expected
results to range from -46 cents to -27 cents per share.
    * Reported revenue was zero​; analysts expected $5.00
million. 
    * Invivyd Inc's reported EPS for the quarter was a loss
of 40
cents​.
    * The company reported a quarterly loss of $47.25 million.
    * Invivyd Inc shares had fallen by 3.6% this quarter and
lost 73.1% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 2.8%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Invivyd Inc is
$9.50 
This summary was machine generated from LSEG data August 14 at
01:36 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.37          -0.40          Missed
 Mar. 31 2024      -0.47          -0.38          Beat
 Dec. 31 2023      -0.42          -0.67          Missed
 Sep. 30 2023      -0.50          -0.36          Beat

Recent news on Invivyd

See all news